Prediction market odds on brain-computer interface milestones
Neuralink is pushing the boundaries of brain-computer interfaces, with ambitious goals to treat neurological conditions and eventually enhance human cognition. Prediction markets track clinical trial milestones, FDA approvals, and the timeline for commercial availability.
Prediction markets price Neuralink milestones based on clinical trial progress, FDA decisions, and patient outcomes. Check the live markets below.
Will Neuralink's valuation hit (HIGH) $100B by December 31?
